1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFamily Support is sponsored by Arms Wide Open Childhood Cancer Foundation. Offers financial assistance to families facing hardship due to a child's cancer diagnosis, including monthly grants and bereavement retreats.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Families residing on the East Coast (Connecticut, Delaware, Florida, Georgia, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, North Carolina, Pennsylvania, Rhode Island, South Carolina, Vermont, Virginia, Washington, D.C., and West Virginia). Confirm the full requirements in the official notice before applying.
Family Support is funded by Arms Wide Open Childhood Cancer Foundation. Verify program details on the funder's official page before applying.
This opportunity targets applicants in 18 states, including North Carolina, South Carolina, Massachusetts, New Hampshire, and West Virginia. Check the official notice for the full list.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
HR001126S0015 accepts executive summaries, abstracts, and proposals on a rolling basis through August 27, 2027. New this cycle: a lighter executive-summary entry point, a 30-day accelerated award path for proposals up to $2 million, a $150,000-per-year talent add-on for university primes, and an explicit bar on FFRDCs, UARCs, and national labs.
Read articleHR001126S0001 accepts abstracts on a rolling basis until November 1, 2026 and invited full proposals until November 30. The BAA was paused in May during an office realignment and restarted in August, compressing a 12-month window into roughly three months of live submission time.
Read articleARPA-H-SOL-26-164 asks teams to compress drug development from a decade to under four years using simulation-designed platform trials — and forbids bidding any single technical area. Solution summaries are mandatory and due November 30, 2026.
Read article